Connect with us


COVID-19 Drug: WHO Resumes Clinical Trials Of Hydroxychloroquine



The suspension of clinical trials of hydroxychloroquine as a potential treatment for coronavirus (COVID-19) has finally been stopped by the world health organisation with the hopes that clinical drug will resume soonest

The resumption of the clinical trials of hydroxychloroquine again as a potential treatment for coronavirus (COVID-19) was announced by WHO’s Director-General, Dr Tedros Ghebreyesus.

Ghebreyesus, who stated this on the official twitter account of the UN health agency, said the hydroxychloroquine section of WHO’s Solidarity Trial can resume after being paused temporarily on May 25.

here is Ghebreyesus series of tweets below about the resumption of the COVID-19 Drug

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.


%d bloggers like this: